Business Wire

NY-ESTÉE-LAUDER

11.5.2021 13:02:09 CEST | Business Wire | Press release

Share
The Estée Lauder Companies Appoints Meridith Webster as Executive Vice President, Global Communications and Public Affairs

The Estée Lauder Companies Inc. (NYSE:EL) announced today that Meridith Webster will join the company in the newly-created role of Executive Vice President, Global Communications and Public Affairs , effective May 17, 2021. Meridith will report jointly to William P. Lauder, Executive Chairman, and Fabrizio Freda, President and Chief Executive Officer. She will also join The Estée Lauder Companies Inc.’s (“ELC”) Executive Leadership Team.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210511005345/en/

Meridith will succeed Alexandra (Alex) Trower as head of Global Communications and Maria Cristina (MC) González Noguera as head of Global Public Affairs. Her appointment follows the news that Alex has made the decision to retire in June after an esteemed career at the company, and that MC was recently tapped for the role of EVP and Chief Communications and Public Affairs Officer at Popular Inc., the Puerto Rico-based global financial services conglomerate.

“Our world-class Global Communications and Public Affairs teams have consistently advanced ahead of the curve against the backdrop of an increasingly complex and rapidly-changing global landscape,” said Fabrizio Freda . “Meridith’s appointment will continue to enable and enhance our delivery of thoughtful, effective communications to our valued global stakeholders as she leads these talented teams to new heights.”

“Meridith’s deep public and private sector experience, coupled with her core values and leadership style, make her uniquely suited to step into this role now,” said William P. Lauder . “I am so proud of the incredible work of our Global Communications and Public Affairs teams and I know they will be in great hands under Meridith’s leadership as she joins our ELC family.”

In this new role, Meridith will lead ELC’s global communications and public affairs strategic agendas to advance and protect its business interests and corporate reputation globally, and strengthen relationships to drive value for key stakeholders. She will serve as a strategic advisor to the ELC’s Executive Leadership Team, the Board of Directors and the Lauder Family on a variety of critical topics.

Meridith will oversee ELC’s Global Communications and Public Affairs teams, elevating the impact of these important functions across the business. She will lead the strategy and delivery of holistic, integrated global communications to advance ELC’s corporate reputation and winning business narrative, while building brand equity and strengthening the platforms that resonate with key audiences internally and externally. She will also lead the global public affairs and stakeholder engagement strategy to further advance ELC’s business goals, build reputation capital and proactively mitigate issues.

Meridith’s deep government experience includes tenures under multiple U.S. presidential administrations. Meridith joins ELC from the Biden White House, where she served as Special Assistant to the President and Chief of Staff to the Domestic Policy Council. At the Obama White House, she served as Senior Advisor to two White House Chiefs of Staff, Rahm Emanuel and Pete Rouse. She also served as Deputy Chief of Staff to Susan Rice, then the U.S. Ambassador to the United Nations. Meridith started her career working at the Clinton White House and the U.S. State Department before earning her J.D. Degree at Georgetown University Law Center.

Prior to serving in the Biden Administration, she served as Vox Media’s first-ever Chief Communications Officer, overseeing strategic and crisis communications and media relations across a growing modern media company, including editorial networks and advertising, studios, and podcasting. She also previously led the Public Affairs practice at Emerson Collective and served as Global Head of Public Affairs at Bloomberg L.P. and Bloomberg Philanthropies where she managed the expansion of the business and established public affairs and communications functions in Washington, New York and globally.

“I am thrilled to be joining The Estée Lauder Companies. Alex and MC each have done a terrific job leading the company’s Global Communications and Public Affairs functions and positioning these talented teams as strategic business partners,” said Meridith Webster . “It is an honor to step into this new role and I am excited to continue building on the successes of these teams in a rapidly-evolving space. I look forward to partnering with Fabrizio, William and the entire Executive Leadership Team to drive the overall success and continued growth of ELC.”

About The Estée Lauder Companies Inc.

The Estée Lauder Companies Inc. is one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, Tommy Hilfiger, M·A·C, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin, TOM FORD BEAUTY, Smashbox, Ermenegildo Zegna, AERIN, RODIN olio lusso, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, BECCA, Too Faced and Dr. Jart+.

ELC-C
ELC-L

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release

REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release

In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye